Dow Up 0.15% Nasdaq Up 0.21%

Avalanche Biotechnologies, Inc. (AAVL)

-NasdaqGM
32.78 Sep 17, 4:00PM EDT
Prev Close:32.78
Open:N/A
Bid:30.00 x 200
Ask:200,000.00 x 100
1y Target Est:44.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:22.00 - 36.78
Volume:0
Avg Vol (3m):312,194
Market Cap:700.18M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AAVL 0.00%700.18M
AGN50.53B
REGN36.05B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,590.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.97
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avalanche Biotechnologies, Inc., a clinical-stage biotechnology company, focuses on discovering and developing novel gene therapies for the treatment of ophthalmic diseases based on its Ocular BioFactory platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback